Weekly injection plans — all-inclusive pricing

Licensed weekly injection pathways are for adults with obesity or overweight with weight-related health problems, where BMI and clinical history meet MHRA-approved criteria. Your prescriber confirms eligibility — we do not rely on self-reported weight alone for high-risk medicines and may ask for verification.

The most common side effects are digestive — nausea, reduced appetite, bloating, constipation or diarrhoea — especially when starting or increasing dose. These often improve as your body adjusts. Your prescriber titrates dose slowly and reviews you regularly. Report severe or persistent symptoms promptly.

You start on a low weekly dose and increase only when your prescriber agrees you are tolerating treatment well. Each dose tier has its own monthly price. Do not increase faster than your care plan recommends.

Follow the patient information leaflet supplied with your pen. Most pens are refrigerated before first use and may be kept at room temperature for a limited period once in use. Never freeze. Use cold-chain delivery packs as guidance and contact us if a pen arrives warm or damaged.

Results vary. Clinical trials show meaningful weight loss over months when injections are combined with diet and activity changes — not from the pen alone. Your clinician sets realistic expectations based on your starting weight and health.

Only with prescriber review. Pathways use different medicines and titration schedules. Book a review through your account if you are not progressing or have side effects — do not switch products without clinical guidance.